
T1I initiated the global #insulin4all campaign in 2014. We accept no money from pharma so we can advocate freely. Registered 501c3 non-profit.
- Tweets14.8K
- Following2.9K
- Followers8.8K
- Likes12.7K

ALT Red background with grey banner. White text on banner reads "Two fears. Every day. That's what Hamza describes living with in Gaza: the thread of the rubble, and the thread of his own blood sugar dropping with no way to treat it". Photo of advocate Hamza holding insulin pens in bottom right corner. T1International logo in bottom left corner.

ALT Photo of Regional Advocacy Consultant Ali standing on the lawn in front of the World Health Assembly (WHA) building, with flags of WHA countries covering the lawn. White text on the photo reads "Reflections on WHA79: Why is the world still not well?" T1International and NCD Alliance logos in the bottom left.

ALT Black and white image of Executive Director Shaina Kasper attending a session at the WHO. Black text on image reads "At the World Health Organization. The Federal Drug Administration in the US. The National Institute for Health and Care Excellence in the UK. The question is always the same: Where is the evidence? This survey answers it". T1International logo in bottom right.

ALT Black and white image of Advocates participating in a panel at NYU. Blue text over image reads "People who live with a condition are not just subjects of research. They are its most essential voices." T1International logo in bottom right.

ALT Graph paper background with black text that reads "I have lived with type 1 diabetes for nine years. That is exactly why I am the right person to do this research. - Amira, Research Fellow, person living with type 1 diabetes, New York, United States". Photo of Amira in bottom right, T1International logo in bottom left.

ALT Graph paper background with black text that reads "The barriers change. The prices change. The problem does not." T1International logo in bottom right.

ALT Graph paper background with black text that reads "When I was diagnosed with type 1 diabetes, I did what engineers do. I solved a problem by building the community I could not find. - Juliana, Research Fellow, person living with type 1 diabetes, Brazil". Photo of Juliana in bottom right. T1International logo in bottom left.

ALT Graph paper background with black text reading ""Every day I see what happens when people with diabetes cannot afford their insulin. Not as a statistic, but as a person who had to make an impossible choice. - Annete, Research Fellow, Kenya". Photo of Annete in bottom right. T1International logo in bottom left.

ALT Graph paper background with black text that reads "One in three people who relies on insulin to survive rations it." T1International logo in bottom right.

ALT Graph paper background with black text that reads "My name is Iqra. I live in Pakistan. I was diagnosed with type 1 diabetes after going into diabetic ketoacidosis, a life-threatening emergency that happens with the body is starved of insulin." Photo of Research Fellow Iqra in bottom right. T1International logo in bottom left.

ALT Background with graph paper lines. Text reads "Tomorrow, we kick off our spring fundraiser. Every dollar raised supports the independent, patient-led research and advocacy our global community relies on. Because the work is not finished until everyone has the insulin they need." T1International logo in bottom right.

ALT Background with graph paper lines. Text reads "But today, 1 in 3 people who rely on insulin to survive still ration it. Not because insulin doesn't exist. Because they cannot access or afford it." T1International logo in bottom right.

ALT Background with graph paper lines and photo of Frederick Banting and Charles Best at the top. Header reads "May 17, 1921." Text below reads "On this day, Frederick Banting and Charles Best, working under J.R.R. Macleod at the University of Toronto, isolated insulin for the first time. James Collip then purified it, making it safe for human injection. Millions of lives became possible." T1International logo in bottom right.


























